Promyelocytic leukaemia (PML) protein expression in human placenta and choriocarcinoma

Chong Jai Kim1, Bo Hyun Yoon, Jong Kwan Jun

  • 1Department of Pathology, Seoul National University College of Medicine, Seoul, Korea. cjkim@plaza.snu.ac.kr

The Journal of Pathology
|September 2, 2003
PubMed

Insights

Promyelocytic leukaemia (PML) protein is crucial for human placental development and growth. Its overexpression in choriocarcinoma cells reduced growth and increased apoptosis, suggesting a role in trophoblastic neoplasia.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Oncology

Background:

  • Promyelocytic leukaemia (PML) protein regulates key cellular processes like growth and differentiation.
  • PML's role in human gestation and placental development is largely uncharacterized.
  • The PML gene fusion is implicated in acute PML tumorigenesis.

Purpose of the Study:

  • To investigate PML expression patterns in the human placenta and choriocarcinoma.
  • To determine the functional significance of PML in placental cells and trophoblastic neoplasia.

Main Methods:

  • Immunoblotting of placental lysates to assess PML expression levels.
  • Adenoviral transduction to overexpress PML in choriocarcinoma cell lines (BeWo and JEG-3).
  • Histological examination of placental tissues, hydatidiform moles, and choriocarcinomas.

Main Results:

  • PML expression increases with gestation in the human placenta, found in stromal fibroblasts, endothelial cells, Hofbauer cells, and amnion cells.
  • PML is selectively expressed in intermediate trophoblasts and syncytiotrophoblastic giant cells at the placental site, but not in villous cytotrophoblasts or syncytiotrophoblasts.
  • PML overexpression in choriocarcinoma cells led to reduced cell growth and increased apoptosis.

Conclusions:

  • PML plays a significant role in human placental development and growth.
  • PML expression patterns are specific to trophoblast subtypes and change during gestation.
  • PML may be involved in the pathobiology of trophoblastic neoplasia, offering potential therapeutic targets.